Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 165

1.

Differences in Consumer Assessment of Healthcare Providers and Systems (CAHPS) Clinician and Group Survey Scores by Recency of the Last Visit: Implications for Comparability of Periodic and Continuous Sampling.

Setodji CM, Burkhart Q, Hays RD, Quigley DD, Skootsky SA, Elliott MN.

Med Care. 2019 May 15. doi: 10.1097/MLR.0000000000001134. [Epub ahead of print]

PMID:
31107400
2.

Core indicators of quality in practice education placement in allied health and social care professions: a scoping review protocol.

Hills C, Quigley D, Bennett AE, Haughey F, McMahon S.

JBI Database System Rev Implement Rep. 2019 Apr 29. doi: 10.11124/JBISRIR-2017-004031. [Epub ahead of print]

PMID:
31045628
3.

ADDENDUM: Section E9 of the American College of Medical Genetics Technical Standards and Guidelines: Fluorescence in situ hybridization.

Mascarello JT, Hirsch B, Kearney HM, Ketterling RP, Olson SB, Quigley DI, Rao KW, Tepperberg JH, Tsuchiya KD, Wiktor AE; A Working Group of the American College of Medical Genetics (ACMG) Laboratory Quality Assurance Committee.

Genet Med. 2019 Apr 26. doi: 10.1038/s41436-019-0508-z. [Epub ahead of print] No abstract available.

PMID:
31028353
4.

Novel RB1-loss transcriptomic signature is associated with poor clinical outcomes across cancer types.

Chen WS, Alshalalfa M, Zhao SG, Liu Y, Mahal BA, Quigley DA, Wei T, Davicioni E, Rebbeck TR, Kantoff PW, Maher CA, Knudsen KE, Small EJ, Nguyen PL, Feng FY.

Clin Cancer Res. 2019 Apr 22. pii: clincanres.0404.2019. doi: 10.1158/1078-0432.CCR-19-0404. [Epub ahead of print]

PMID:
31010837
5.

Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate Cancer.

Chen WS, Aggarwal R, Zhang L, Zhao SG, Thomas GV, Beer TM, Quigley DA, Foye A, Playdle D, Huang J, Lloyd P, Lu E, Sun D, Guan X, Rettig M, Gleave M, Evans CP, Youngren J, True L, Lara P, Kothari V, Xia Z, Chi KN, Reiter RE, Maher CA, Feng FY, Small EJ, Alumkal JJ; West Coast Prostate Cancer Dream Team.

Eur Urol. 2019 Mar 27. pii: S0302-2838(19)30206-4. doi: 10.1016/j.eururo.2019.03.020. [Epub ahead of print]

PMID:
30928160
6.

Whole Genome and Transcriptional Analysis of Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer Demonstrates Intra-Class Heterogeneity.

Aggarwal RR, Quigley DA, Huang J, Zhang L, Beer TM, Rettig MB, Reiter RE, Gleave ME, Thomas GV, Foye A, Playdle D, Lloyd P, Chi KN, Evans CP, Lara PN, Feng FY, Alumkal JJ, Small EJ.

Mol Cancer Res. 2019 Mar 27. pii: molcanres.1101.2018. doi: 10.1158/1541-7786.MCR-18-1101. [Epub ahead of print]

PMID:
30918106
7.

The expansion of National Healthcare Safety Network enrollment and reporting in nursing homes: Lessons learned from a national qualitative study.

Stone PW, Chastain AM, Dorritie R, Tark A, Dick AW, Bell JM, Stone ND, Quigley DD, Sorbero ME.

Am J Infect Control. 2019 Mar 5. pii: S0196-6553(19)30074-4. doi: 10.1016/j.ajic.2019.02.005. [Epub ahead of print]

PMID:
30850253
8.

High density is a property of slow-cycling and treatment-resistant human glioblastoma cells.

Sabelström H, Quigley DA, Fenster T, Foster DJ, Fuchshuber CAM, Saxena S, Yuan E, Li N, Paterno F, Phillips JJ, James CD, Norling B, Berger MS, Persson AI.

Exp Cell Res. 2019 May 1;378(1):76-86. doi: 10.1016/j.yexcr.2019.03.003. Epub 2019 Mar 5.

9.

An Integrated Approach to Measuring Sexual Orientation Disparities in Women's Access to Health Services: A National Health Interview Survey Application.

MacCarthy S, Martino SC, Burkhart Q, Beckett MK, Schuster MA, Quigley DD, Ng JH, Agniel D, Elliott MN.

LGBT Health. 2019 Feb/Mar;6(2):87-93. doi: 10.1089/lgbt.2018.0190. Epub 2019 Feb 6.

PMID:
30724685
10.

Inpatient care experiences differ by preferred language within racial/ethnic groups.

Quigley DD, Elliott MN, Hambarsoomian K, Wilson-Frederick SM, Lehrman WG, Agniel D, Ng JH, Goldstein EH, Giordano LA, Martino SC.

Health Serv Res. 2019 Feb;54 Suppl 1:263-274. doi: 10.1111/1475-6773.13105. Epub 2019 Jan 6.

PMID:
30613960
11.

Clinical and Genomic Implications of Luminal and Basal Subtypes Across Carcinomas.

Zhao SG, Chen WS, Das R, Chang SL, Tomlins SA, Chou J, Quigley DA, Dang HX, Barnard TJ, Mahal BA, Gibb EA, Liu Y, Davicioni E, Duska LR, Posadas EM, Jolly S, Spratt DE, Nguyen PL, Maher CA, Small EJ, Feng FY.

Clin Cancer Res. 2019 Apr 15;25(8):2450-2457. doi: 10.1158/1078-0432.CCR-18-3121. Epub 2018 Dec 20.

PMID:
30573691
12.

Principles and procedures for handling out-of-domain and indeterminate results as part of ICH M7 recommended (Q)SAR analyses.

Amberg A, Andaya RV, Anger LT, Barber C, Beilke L, Bercu J, Bower D, Brigo A, Cammerer Z, Cross KP, Custer L, Dobo K, Gerets H, Gervais V, Glowienke S, Gomez S, Van Gompel J, Harvey J, Hasselgren C, Honma M, Johnson C, Jolly R, Kemper R, Kenyon M, Kruhlak N, Leavitt P, Miller S, Muster W, Naven R, Nicolette J, Parenty A, Powley M, Quigley DP, Reddy MV, Sasaki JC, Stavitskaya L, Teasdale A, Trejo-Martin A, Weiner S, Welch DS, White A, Wichard J, Woolley D, Myatt GJ.

Regul Toxicol Pharmacol. 2019 Mar;102:53-64. doi: 10.1016/j.yrtph.2018.12.007. Epub 2018 Dec 15.

13.

Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.

Quigley DA, Dang HX, Zhao SG, Lloyd P, Aggarwal R, Alumkal JJ, Foye A, Kothari V, Perry MD, Bailey AM, Playdle D, Barnard TJ, Zhang L, Zhang J, Youngren JF, Cieslik MP, Parolia A, Beer TM, Thomas G, Chi KN, Gleave M, Lack NA, Zoubeidi A, Reiter RE, Rettig MB, Witte O, Ryan CJ, Fong L, Kim W, Friedlander T, Chou J, Li H, Das R, Li H, Moussavi-Baygi R, Goodarzi H, Gilbert LA, Lara PN Jr, Evans CP, Goldstein TC, Stuart JM, Tomlins SA, Spratt DE, Cheetham RK, Cheng DT, Farh K, Gehring JS, Hakenberg J, Liao A, Febbo PG, Shon J, Sickler B, Batzoglou S, Knudsen KE, He HH, Huang J, Wyatt AW, Dehm SM, Ashworth A, Chinnaiyan AM, Maher CA, Small EJ, Feng FY.

Cell. 2018 Oct 18;175(3):889. doi: 10.1016/j.cell.2018.10.019. No abstract available.

14.

Impact of Data Presentation on Physician Performance Utilizing Artificial Intelligence-Based Computer-Aided Diagnosis and Decision Support Systems.

Barinov L, Jairaj A, Becker M, Seymour S, Lee E, Schram A, Lane E, Goldszal A, Quigley D, Paster L.

J Digit Imaging. 2019 Jun;32(3):408-416. doi: 10.1007/s10278-018-0132-5.

15.

Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: is aromatic N-oxide a structural alert for predicting DNA-reactive mutagenicity?

Amberg A, Anger LT, Bercu J, Bower D, Cross KP, Custer L, Harvey JS, Hasselgren C, Honma M, Johnson C, Jolly R, Kenyon MO, Kruhlak NL, Leavitt P, Quigley DP, Miller S, Snodin D, Stavitskaya L, Teasdale A, Trejo-Martin A, White AT, Wichard J, Myatt GJ.

Mutagenesis. 2019 Mar 6;34(1):67-82. doi: 10.1093/mutage/gey020.

PMID:
30189015
16.

DNA Repair Gene Alterations and PARP Inhibitor Response in Patients With Metastatic Castration-Resistant Prostate Cancer.

Lu E, Thomas GV, Chen Y, Wyatt AW, Lloyd P, Youngren J, Quigley D, Bergan R, Bailey S, Beer TM, Feng FY, Small EJ, Alumkal JJ.

J Natl Compr Canc Netw. 2018 Aug;16(8):933-937. doi: 10.6004/jnccn.2018.7020.

PMID:
30099369
17.

Physician Reporting Requirements for Injured Workers in California: A Review of Reporting Processes and Payment Policies.

Quigley DD, Doyle MB, Wynn BO.

Rand Health Q. 2018 Mar 30;7(4):5. eCollection 2018 Mar.

18.

Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.

Quigley DA, Dang HX, Zhao SG, Lloyd P, Aggarwal R, Alumkal JJ, Foye A, Kothari V, Perry MD, Bailey AM, Playdle D, Barnard TJ, Zhang L, Zhang J, Youngren JF, Cieslik MP, Parolia A, Beer TM, Thomas G, Chi KN, Gleave M, Lack NA, Zoubeidi A, Reiter RE, Rettig MB, Witte O, Ryan CJ, Fong L, Kim W, Friedlander T, Chou J, Li H, Das R, Li H, Moussavi-Baygi R, Goodarzi H, Gilbert LA, Lara PN Jr, Evans CP, Goldstein TC, Stuart JM, Tomlins SA, Spratt DE, Cheetham RK, Cheng DT, Farh K, Gehring JS, Hakenberg J, Liao A, Febbo PG, Shon J, Sickler B, Batzoglou S, Knudsen KE, He HH, Huang J, Wyatt AW, Dehm SM, Ashworth A, Chinnaiyan AM, Maher CA, Small EJ, Feng FY.

Cell. 2018 Jul 26;174(3):758-769.e9. doi: 10.1016/j.cell.2018.06.039. Epub 2018 Jul 19. Erratum in: Cell. 2018 Oct 18;175(3):889.

19.

NaCl nucleation from brine in seeded simulations: Sources of uncertainty in rate estimates.

Zimmermann NER, Vorselaars B, Espinosa JR, Quigley D, Smith WR, Sanz E, Vega C, Peters B.

J Chem Phys. 2018 Jun 14;148(22):222838. doi: 10.1063/1.5024009.

PMID:
29907041
20.

Patient Preferences Regarding Shared Decision Making in the Emergency Department: Findings From a Multisite Survey.

Schoenfeld EM, Kanzaria HK, Quigley DD, Marie PS, Nayyar N, Sabbagh SH, Gress KL, Probst MA.

Acad Emerg Med. 2018 Oct;25(10):1118-1128. doi: 10.1111/acem.13499. Epub 2018 Jul 19.

PMID:
29897639
21.

Electronic Structure Control of Sub-nanometer 1D SnTe via Nanostructuring within Single-Walled Carbon Nanotubes.

Vasylenko A, Marks S, Wynn JM, Medeiros PVC, Ramasse QM, Morris AJ, Sloan J, Quigley D.

ACS Nano. 2018 Jun 26;12(6):6023-6031. doi: 10.1021/acsnano.8b02261. Epub 2018 May 25.

22.

In silico toxicology protocols.

Myatt GJ, Ahlberg E, Akahori Y, Allen D, Amberg A, Anger LT, Aptula A, Auerbach S, Beilke L, Bellion P, Benigni R, Bercu J, Booth ED, Bower D, Brigo A, Burden N, Cammerer Z, Cronin MTD, Cross KP, Custer L, Dettwiler M, Dobo K, Ford KA, Fortin MC, Gad-McDonald SE, Gellatly N, Gervais V, Glover KP, Glowienke S, Van Gompel J, Gutsell S, Hardy B, Harvey JS, Hillegass J, Honma M, Hsieh JH, Hsu CW, Hughes K, Johnson C, Jolly R, Jones D, Kemper R, Kenyon MO, Kim MT, Kruhlak NL, Kulkarni SA, Kümmerer K, Leavitt P, Majer B, Masten S, Miller S, Moser J, Mumtaz M, Muster W, Neilson L, Oprea TI, Patlewicz G, Paulino A, Lo Piparo E, Powley M, Quigley DP, Reddy MV, Richarz AN, Ruiz P, Schilter B, Serafimova R, Simpson W, Stavitskaya L, Stidl R, Suarez-Rodriguez D, Szabo DT, Teasdale A, Trejo-Martin A, Valentin JP, Vuorinen A, Wall BA, Watts P, White AT, Wichard J, Witt KL, Woolley A, Woolley D, Zwickl C, Hasselgren C.

Regul Toxicol Pharmacol. 2018 Jul;96:1-17. doi: 10.1016/j.yrtph.2018.04.014. Epub 2018 Apr 17.

23.

Patient-reported denials, appeals, and complaints: associations with overall plan ratings.

Quigley DD, Haviland AM, Dembosky JW, Klein DJ, Elliott MN.

Am J Manag Care. 2018 Mar 1;24(3):e86-e92.

24.

Commonly Occurring Cell Subsets in High-Grade Serous Ovarian Tumors Identified by Single-Cell Mass Cytometry.

Gonzalez VD, Samusik N, Chen TJ, Savig ES, Aghaeepour N, Quigley DA, Huang YW, Giangarrà V, Borowsky AD, Hubbard NE, Chen SY, Han G, Ashworth A, Kipps TJ, Berek JS, Nolan GP, Fantl WJ.

Cell Rep. 2018 Feb 13;22(7):1875-1888. doi: 10.1016/j.celrep.2018.01.053.

25.

Quantifying Magnitude of Group-Level Differences in Patient Experiences with Health Care.

Quigley DD, Elliott MN, Setodji CM, Hays RD.

Health Serv Res. 2018 Aug;53 Suppl 1:3027-3051. doi: 10.1111/1475-6773.12828. Epub 2018 Feb 12.

PMID:
29435975
26.

Antisecretory Factor-Mediated Inhibition of Cell Volume Dynamics Produces Antitumor Activity in Glioblastoma.

Ilkhanizadeh S, Sabelström H, Miroshnikova YA, Frantz A, Zhu W, Idilli A, Lakins JN, Schmidt C, Quigley DA, Fenster T, Yuan E, Trzeciak JR, Saxena S, Lindberg OR, Mouw JK, Burdick JA, Magnitsky S, Berger MS, Phillips JJ, Arosio D, Sun D, Weaver VM, Weiss WA, Persson AI.

Mol Cancer Res. 2018 May;16(5):777-790. doi: 10.1158/1541-7786.MCR-17-0413. Epub 2018 Feb 5.

27.

Survey on Using Ethical Principles in Environmental Field Research with Place-Based Communities.

Quigley D, Levine A, Sonnenfeld DA, Brown P, Tian Q, Wei X.

Sci Eng Ethics. 2019 Apr;25(2):477-517. doi: 10.1007/s11948-017-9981-4. Epub 2018 Jan 3.

PMID:
29299754
28.

Patient Experience With Care and Its Association With Adherence to Hypertension Medications.

Fortuna RJ, Nagel AK, Rocco TA, Legette-Sobers S, Quigley DD.

Am J Hypertens. 2018 Feb 9;31(3):340-345. doi: 10.1093/ajh/hpx200.

PMID:
29253071
29.

Age, estrogen, and immune response in breast adenocarcinoma and adjacent normal tissue.

Quigley DA, Tahiri A, Lüders T, Riis MH, Balmain A, Børresen-Dale AL, Bukholm I, Kristensen V.

Oncoimmunology. 2017 Aug 10;6(11):e1356142. doi: 10.1080/2162402X.2017.1356142. eCollection 2017.

30.

Developing and Testing the Health Care Safety Hotline: A Prototype Consumer Reporting System for Patient Safety Events.

Schneider EC, Ridgely MS, Quigley DD, Hunter LE, Leuschner KJ, Weingart SN, Weissman JS, Zimmer KP, Giannini RC.

Rand Health Q. 2017 Jun 19;6(3):1. eCollection 2017 Jun.

31.

Nucleation barrier reconstruction via the seeding method in a lattice model with competing nucleation pathways.

Lifanov Y, Vorselaars B, Quigley D.

J Chem Phys. 2016 Dec 7;145(21):211912. doi: 10.1063/1.4962216.

PMID:
28799399
32.

Implementation of Practice Transformation: Patient Experience According to Practice Leaders.

Quigley DD, Palimaru AI, Chen AY, Hays RD.

Qual Manag Health Care. 2017 Jul/Sep;26(3):140-151. doi: 10.1097/QMH.0000000000000141.

33.

Implementation and evaluation of a prototype consumer reporting system for patient safety events.

Weingart SN, Weissman JS, Zimmer KP, Giannini RC, Quigley DD, Hunter LE, Ridgely MS, Schneider EC.

Int J Qual Health Care. 2017 Aug 1;29(4):521-526. doi: 10.1093/intqhc/mzx060.

PMID:
28541430
34.

Single-Atom Scale Structural Selectivity in Te Nanowires Encapsulated Inside Ultranarrow, Single-Walled Carbon Nanotubes.

Medeiros PVC, Marks S, Wynn JM, Vasylenko A, Ramasse QM, Quigley D, Sloan J, Morris AJ.

ACS Nano. 2017 Jun 27;11(6):6178-6185. doi: 10.1021/acsnano.7b02225. Epub 2017 May 15.

35.

Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of BRCA2 Reversion Mutations Associated with Resistance to PARP Inhibitors.

Quigley D, Alumkal JJ, Wyatt AW, Kothari V, Foye A, Lloyd P, Aggarwal R, Kim W, Lu E, Schwartzman J, Beja K, Annala M, Das R, Diolaiti M, Pritchard C, Thomas G, Tomlins S, Knudsen K, Lord CJ, Ryan C, Youngren J, Beer TM, Ashworth A, Small EJ, Feng FY.

Cancer Discov. 2017 Sep;7(9):999-1005. doi: 10.1158/2159-8290.CD-17-0146. Epub 2017 Apr 27.

36.

Patient Experiences with Care Differ with Chronic Care Management in a Federally Qualified Community Health Center.

Setodji CM, Quigley DD, Elliott MN, Burkhart Q, Hochman ME, Chen AY, Hays RD.

Popul Health Manag. 2017 Dec;20(6):442-448. doi: 10.1089/pop.2017.0003. Epub 2017 Apr 7.

37.

Solid-liquid interfacial free energy of ice Ih, ice Ic, and ice 0 within a mono-atomic model of water via the capillary wave method.

Ambler M, Vorselaars B, Allen MP, Quigley D.

J Chem Phys. 2017 Feb 21;146(7):074701. doi: 10.1063/1.4975776.

PMID:
28228014
38.

Correction: Folding kinetics of a polymer.

Vorselaars B, Růžička Š, Quigley D, Allen MP.

Phys Chem Chem Phys. 2017 Feb 15;19(7):5674-5676. doi: 10.1039/c7cp90027a.

PMID:
28165101
39.

Implementation and Sequencing of Practice Transformation in Urban Practices with Underserved Patients.

Quigley DD, Predmore ZS, Chen AY, Hays RD.

Qual Manag Health Care. 2017 Jan/Mar;26(1):7-14. doi: 10.1097/QMH.0000000000000118.

40.

Panx3 links body mass index and tumorigenesis in a genetically heterogeneous mouse model of carcinogen-induced cancer.

Halliwill KD, Quigley DA, Kang HC, Del Rosario R, Ginzinger D, Balmain A.

Genome Med. 2016 Aug 9;8(1):83. doi: 10.1186/s13073-016-0334-8.

41.

Gene Expression Architecture of Mouse Dorsal and Tail Skin Reveals Functional Differences in Inflammation and Cancer.

Quigley DA, Kandyba E, Huang P, Halliwill KD, Sjölund J, Pelorosso F, Wong CE, Hirst GL, Wu D, Delrosario R, Kumar A, Balmain A.

Cell Rep. 2016 Jul 26;16(4):1153-1165. doi: 10.1016/j.celrep.2016.06.061. Epub 2016 Jul 14.

42.

Taking Advantage of Databases.

Myatt GJ, Quigley DP.

Methods Mol Biol. 2016;1425:383-430. doi: 10.1007/978-1-4939-3609-0_17.

PMID:
27311475
43.

Enhancement of island size by dynamic substrate disorder in simulations of graphene growth.

Enstone G, Brommer P, Quigley D, R Bell G.

Phys Chem Chem Phys. 2016 Jun 1;18(22):15102-9. doi: 10.1039/c6cp00788k.

PMID:
27199250
44.

Large-Scale Profiling of Kinase Dependencies in Cancer Cell Lines.

Campbell J, Ryan CJ, Brough R, Bajrami I, Pemberton HN, Chong IY, Costa-Cabral S, Frankum J, Gulati A, Holme H, Miller R, Postel-Vinay S, Rafiq R, Wei W, Williamson CT, Quigley DA, Tym J, Al-Lazikani B, Fenton T, Natrajan R, Strauss SJ, Ashworth A, Lord CJ.

Cell Rep. 2016 Mar 15;14(10):2490-501. doi: 10.1016/j.celrep.2016.02.023. Epub 2016 Mar 3.

45.

Generating a taxonomy for genetic conditions relevant to reproductive planning.

Korngiebel DM, McMullen CK, Amendola LM, Berg JS, Davis JV, Gilmore MJ, Harding CO, Himes P, Jarvik GP, Kauffman TL, Kennedy KA, Simpson DK, Leo MC, Lynch FL, Quigley DI, Reiss JA, Richards CS, Rope AF, Schneider JL, Goddard KA, Wilfond BS.

Am J Med Genet A. 2016 Mar;170(3):565-73. doi: 10.1002/ajmg.a.37513.

46.

Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicity.

Ahlberg E, Amberg A, Beilke LD, Bower D, Cross KP, Custer L, Ford KA, Van Gompel J, Harvey J, Honma M, Jolly R, Joossens E, Kemper RA, Kenyon M, Kruhlak N, Kuhnke L, Leavitt P, Naven R, Neilan C, Quigley DP, Shuey D, Spirkl HP, Stavitskaya L, Teasdale A, White A, Wichard J, Zwickl C, Myatt GJ.

Regul Toxicol Pharmacol. 2016 Jun;77:1-12. doi: 10.1016/j.yrtph.2016.02.003. Epub 2016 Feb 13.

PMID:
26879463
47.

Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses.

Amberg A, Beilke L, Bercu J, Bower D, Brigo A, Cross KP, Custer L, Dobo K, Dowdy E, Ford KA, Glowienke S, Van Gompel J, Harvey J, Hasselgren C, Honma M, Jolly R, Kemper R, Kenyon M, Kruhlak N, Leavitt P, Miller S, Muster W, Nicolette J, Plaper A, Powley M, Quigley DP, Reddy MV, Spirkl HP, Stavitskaya L, Teasdale A, Weiner S, Welch DS, White A, Wichard J, Myatt GJ.

Regul Toxicol Pharmacol. 2016 Jun;77:13-24. doi: 10.1016/j.yrtph.2016.02.004. Epub 2016 Feb 11.

48.

Patients' ratings of genetic conditions validate a taxonomy to simplify decisions about preconception carrier screening via genome sequencing.

Leo MC, McMullen C, Wilfond BS, Lynch FL, Reiss JA, Gilmore MJ, Himes P, Kauffman TL, Davis JV, Jarvik GP, Berg JS, Harding C, Kennedy KA, Simpson DK, Quigley DI, Richards CS, Rope AF, Goddard KA.

Am J Med Genet A. 2016 Mar;170(3):574-82. doi: 10.1002/ajmg.a.37477. Epub 2016 Jan 21.

49.

Effectiveness of a multidisciplinary intervention to improve hypertension control in an urban underserved practice.

Fortuna RJ, Nagel AK, Rose E, McCann R, Teeters JC, Quigley DD, Bisognano JD, Legette-Sobers S, Liu C, Rocco TA.

J Am Soc Hypertens. 2015 Dec;9(12):966-74. doi: 10.1016/j.jash.2015.10.004. Epub 2015 Oct 26.

PMID:
26687551
50.

Predicting prognosis and therapeutic response from interactions between lymphocytes and tumor cells.

Quigley DA, Kristensen V.

Mol Oncol. 2015 Dec;9(10):2054-62. doi: 10.1016/j.molonc.2015.10.003. Epub 2015 Oct 23. Review.

Supplemental Content

Loading ...
Support Center